Market Reaction to Trump's Tariff Plans

Following US President Donald Trump's announcement of a "major tariff" on pharmaceuticals, stocks of leading European pharmaceutical companies experienced a significant downturn. This move has sparked widespread concern among investors regarding its potential ripple effects across the global market.

Notable Declines

At 10:18 am CET, Novartis AG and Roche Holding AG saw their shares plummet by 7.03% and 5.80%, respectively. Shortly after, at 10:32 am CET, Sanofi SA's shares dropped by 5.64%. Similarly, AstraZeneca PLC and GSK plc were not spared, with their shares sliding by 6.27% and 5.74%, respectively.

Investor Concerns

The announcement has led to heightened anxiety among investors, who are now closely monitoring the situation for further developments. The potential impact of these tariffs on the pharmaceutical sector and broader market remains a critical point of discussion.